Chronic kidney disease

Related records

Broader conditions (5)

• Disease
• Disease by body system or component
• Human disease
• Kidney disorder
• Urinary system disorder

Narrower conditions (7)

• Arterionephrosclerosis
• Chronic pyelonephritis
• Chronic rapidly progressive glomerulonephritis
• Chronic renal failure syndrome
• Diabetic kidney disease
• End stage renal failure
• Xanthogranulomatous pyelonephritis

Trials (2,256)

• "Hypoxic vs. Aerobic Training in Chronic Kidney Disease
• "Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"
• 12 Weeks of Hemodialysis With Medium Cut-Off Filter Compared to Hemodiafiltration With Standard High-flux Filter.
• 20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
• 20070360 Incident Dialysis
• 24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease
• 2D-speckle Tracking in Pediatric Renal Chronic Disease
• 4-7-8 Breathing for Fatigue and Sleep Management in Hemodialysis
• A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
• A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
• A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
• A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients
• A Clinical Study to Evaluate the Safety, Tolerability and Activity of a New Phosphate Binder (SBR759) in Patients With Chronic Kidney Disease on Hemodialysis
• A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
• A Clinical Trial to Define the Best Strategy for the Management of Heart Failure in Elderly Patients
• A Cluster Randomized Trial to Assess the Impact of Patient and Provider Education on Use of Home Dialysis
• A Cohort Study on the Integrated Management of Chronic Kidney Disease
• A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
• A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
• A Comparative Study of Intradialytic vs. Pre-Dialysis Physical Therapy Interventions in Individuals Undergoing Hemodialysis: A Randomized Controlled Trial

Approved drugs (48)

• Ascorbic acid
• Biotin
• Calcifediol
• Calcitriol
• Calcium acetate
• Ceftaroline fosamil acetate
• Chlorothiazide
• Chlorthalidone
• Cinacalcet hydrochloride
• Cyanocobalamin
• Dapagliflozin
• Dapagliflozin propanediol
• Daprodustat
• Darbepoetin alfa
• Difelikefalin acetate
• Doxercalciferol
• Empagliflozin
• Epoetin alfa
• Epoetin beta
• Epoetin delta

Drugs in development (204)

• Acetylcysteine Phase 3
• Alcohol Phase 2
• Aliskiren Phase 1
• Allopurinol Phase 2
• Amisulpride Phase 1
• Anakinra Phase 2
• Apixaban Phase 2
• Aspirin Phase 3
• Atorvastatin Phase 3
• Atorvastatin calcium Phase 3
• Atrasentan Phase 2
• Atuliflapon Phase 2
• AUS-131 Phase 2
• Avacopan Phase 1
• Avenciguat Phase 2
• Azathioprine Phase 3
• Balcinrenone Phase 2
• Bardoxolone methyl Phase 2
• Baricitinib Phase 2
• Basiliximab Phase 2

Other linked drugs (20)

• Alteplase
• Amino acids
• Benazepril
• Bixalomer
• Domperidone
• Fepixnebart
• Insulin glargine
• Inulin
• Inuline
• Lactulose
• Lorazepam
• Montelukast
• Nitroglycerin
• Phenacetin
• Physioneal
• Ropivacaine
• Tacrolimus
• Tamsulosin
• Tenofovir disoproxil fumarate
• Vonsetamig